Manufacturability and the Winners in Advanced Therapies
By Stephanie Vine
January 13, 2026
Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.
7 min read
False
Advertisement
Technology & Manufacturing
The Future of Precision Medicine is Radiopharmaceuticals
By Mona-Elisabeth Rootwelt-Revheim
January 12, 2026
Here’s why so many people in the industry are excited about the potential of radiopharmaceuticals for diagnosis and treatment.
5 min read
The Truth About Softgels: Phthalate-Free, Powered by Glycerin and Sorbitol
By Stephen Tindal
January 9, 2026
Catalent offers clarification after recent discussions raised concerns around softgels, phthalates and potential health risks
3 min read
Inside 2026: The Industry’s AI Turning Point
January 7, 2026
The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.
6 min read
Building the Future of RNA Manufacturing
By Stefan Lutz
January 6, 2026
Can enzyme-catalyzed processes address the limitations of traditional RNA synthesis and define the future of scalable, sustainable manufacturing of RNA therapeutics?
5 min read
Addressing the Regulatory Documentation Bottleneck to Transform Drug Approvals
By Anita Modi
December 29, 2025
Agentic AI combined with human control points creates a new paradigm for accelerating documentation while maintaining regulatory integrity.
5 min read
How Mixing FSP and FSO Models Bring Agility to Modern Clinical Development
By Les Enterline
December 15, 2025
Clinical trials are becoming longer, costlier and more complex, but a growing number of sponsors are finding agility in a hybrid approach.
4 min read
Rebuilding Confidence in UK Pharma Manufacturing
By Martyn Williams
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
Drug Delivery is Biotech’s Blind Spot. Here’s How we Fix it With Excipients
By Lisa Stehno-Bittel
December 8, 2025
Drug delivery innovation lags behind molecule discovery. Smarter polymer-based excipients can boost biologic stability, efficacy, and accessibility, transforming patient outcomes and biotech success.
3 min read
Making CAR T Truly Off the Shelf
By Hendrik Dietz
December 5, 2025
Could a single infusion transform a patient’s own T cells into cancer-fighting machines? Researchers are betting on single-stranded DNA and lipid nanoparticles to make in vivo CAR-T a scalable reality.
3 min read
